Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends



Rating:

Share or cite this content

Citations should be made in the following way:
A. Hoffmann-Vold (Oslo, Norway), C. Brunborg (Oslo, Norway), F. Tirelli (Zurich, Switzerland), P. Carreira (Madrid, Spain), N. Del Papa (Milan, Italy), A. Mekinian (Paris, France), M. Vonk (Nijmegen, Netherlands), A. Giollo (Verona, Italy), G. De Luca (Milan, Italy), M. De Santis (Milan, Italy), C. Campochiaro (Milan, Italy), C. Mihai (Zurich, Switzerland), P. Airo (Brescia, Italy), M. Lazzaroni (Brescia, Italy), E. Zanatta (Padova, Italy), R. Foti (Catania, Italy), Y. Allanore (Paris, France), D. Furst (

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
• Patterns of cardiopulmonary response to exercise in cardiac diseases
• Evaluating the prognosis of cardiac and pulmonary patients

Related content which might interest you: Impact of ILD severity and subtype on outcomes in CTD-associated PAH Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 PROMising developments in IPF patient-reported outcome measures Source: Eur Respir J, 59 (1) 2102312; 10.1183/13993003.02312-2021 Year: 2022 Impact of pulmonary hypertension after lung transplantation on functional outcome Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Outcome predictive factors in patients with sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Effects of NAC on outcome variables in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 14s Year: 2004 Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Impact of age in the clinical expression of COPD Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180075; 10.1183/16000617.0075-2018 Year: 2018 Comorbidity in lung cancer – operated patients. Impact on survival and prognosis Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 SADL scale as a predictor of mortality in patients with ILD associated with Scleroderma Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Association between patient-reported outcomes and functional test outcomes in patients with COPD before undergoing home-based pulmonary rehabilitation. Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Impact of fatigue improvement after pulmonary rehabilitation education on the long-term prognosis of patients with COPD Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Markers of asthma outcome Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary rehabilitation: COPD severity and functional outcome Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004